Clincosm LogoSign in Get a demo

Small Lymphocytic Lymphoma

Showing 76 - 100 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • IOV-2001
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 31, 2022

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

Non-hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (ZX-101A)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Gilbert, Arizona
  • +5 more
Jan 14, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T

Terminated
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • LUCAR-20S CAR-T cells
  • Hefei, Anhui, China
  • +2 more
Dec 17, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
    • Alessandria, Italy
    • +17 more
    Jan 3, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +2 more
    • Tafasitamab
    • +2 more
    • Jacksonville, Florida
    • +16 more
    Dec 10, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Little Rock, Arkansas
    • +144 more
    Dec 3, 2021

    Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • +8 more
    • Dose combination 1-1
    • +5 more
    • (no location specified)
    Nov 1, 2021

    Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

    Completed
    • Relapsed or Refractory Haematological Malignancies Including
    • +10 more
    • Aachen, Germany
    • +11 more
    Oct 21, 2021

    Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (APG-2575, Rituximab, Ibrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Beijing, Beijing, China
    • +17 more
    Sep 2, 2021

    Non-hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (IMMU-114)

    Terminated
    • Non-hodgkin's Lymphoma
    • +5 more
    • Newark, Delaware
    • +4 more
    Aug 12, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +2 more
    Aug 9, 2021

    Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +3 more
    • LUCAR-20S CAR-T cells
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 5, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Post-Chlorambucil Therapy Follow-up
    • +4 more
    • Duarte, California
    • +106 more
    Aug 6, 2021

    Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in London (NVG-111, NVG-111 (RP2D))

    Recruiting
    • Chronic Lymphocytic Leukaemia
    • +2 more
    • London, United Kingdom
      University College London Hospital
    Jun 22, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

    Recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    May 21, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in La Jolla (Venetoclax, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • La Jolla, California
      UC San Diego Moores Cancer Center
    May 6, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • High Dose Methylprednisolone (HDMP)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Apr 2, 2021

    Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Aichi, Miyagi, Tokyo (Idelalisib)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Aichi, Japan
    • +2 more
    Feb 24, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

    Completed
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • La Jolla, California
    • +68 more
    Mar 15, 2021

    Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Duvelisib, Placebo,

    Withdrawn
    • Indolent Non-Hodgkin's Lymphoma
    • +3 more
    • Plainville, Connecticut
    • +6 more
    Mar 15, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Duvelisib)

    Withdrawn
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Tempe, Arizona
    • +7 more
    Mar 15, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Norway, Sweden (Ibrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Trondheim, Norway
    • +8 more
    Feb 24, 2021